US 8003755
Hydrochloride salts of a glycopeptide phosphonate derivative
granted A61PA61P31/00A61P31/04
Quick answer
US patent 8003755 (Hydrochloride salts of a glycopeptide phosphonate derivative) held by Theravance, Inc. expires Mon Aug 18 2031 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Theravance, Inc.
- Grant date
- Tue Aug 23 2011 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Aug 18 2031 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 5
- CPC classes
- A61P, A61P31/00, A61P31/04